{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/84977"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/84977","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Mechanism of Insulin Release From Islets of Langerhans in a Rat Model of Normal Infants and Infants of Diabetic Mothers","abstract":"Neonatal hypoglycemia is common in infants of diabetic mothers (IDM). The hypoglycemia is believed to result from persistent insulin hypersecretion due to the elevated glucose concentration in utero. The mechanism for the hypersecretion of insulin is not known. The glucose sensing mechanism in the fetal and neonatal IDM and normal control rats was investigated. Pregnant rats were given an i.p. injection of streptozotocin (65 mg/kg) on day 13 of pregnancy to induce diabetes mellitus. Offspring were evaluated on days $-$1, 1, 2, 5 and 10 of life. Parameters measured were body weight, plasma glucose and insulin, in vitro glucose-stimulated insulin release, and protein expression of GLUT1, GLUT2, and glucokinase by immunocytochemistry in the isolated islet and Western blot on the whole pancreas. The IDM had significantly lower mean body weights at all ages studied (p $<$ 0.01, n $\\ge$ 34); significantly higher mean plasma glucose concentration at day $-$1 (p $<$ 0.0001, n $\\ge$ 181) and significantly lower mean plasma glucose at all neonatal ages (p $<$ 0.01, n $\\ge$ 36). Mean plasma insulin was significantly lower at all ages except for day 10 of life (p $<$ 0.05, n $\\ge$ 26). The IDM group mean for the in vitro glucose-stimulated insulin release data was significantly greater than controls (p $<$ 0.0001, n $\\ge$ 4). The insulin release in the IDM was significantly higher on specific days: day $-$1 at glucose concentration of 11.1 and 22.2 mmol/L (p $<$ 0.05, n $\\ge$ 4); day 1 at glucose concentration of 5.5 mmol/L (p $<$ 0.05, n = 6 experiments); and day 2 at glucose concentration of 11.1 mmol/L 22.2 mmol/L (p $<$ 0.05, n $\\ge$ 6). By immunocytochemistry, the IDM had greater GLUT1 protein expression on days 1, 2, and 5 (n = 5 replicates); greater GLUT2 expression on days $-$1, 1, and 5 (n = 7 replicates); and greater glucokinase expression on days 1, 2, and 10 (n = 4 replicates). Western blot data revealed significantly lower GLUT2 protein expression in the IDM on days $-$1 and 2 (p $<$ 0.05, n = 4). These data confirm the elevated insulin release in IDM and suggest that glucose transporter and glucokinase proteins involved in glucose sensing are altered in the IDM.","abstract_html":"Neonatal hypoglycemia is common in infants of diabetic mothers (IDM). The hypoglycemia is believed to result from persistent insulin hypersecretion due to the elevated glucose concentration in utero. The mechanism for the hypersecretion of insulin is not known. The glucose sensing mechanism in the fetal and neonatal IDM and normal control rats was investigated. Pregnant rats were given an i.p. injection of streptozotocin (65 mg/kg) on day 13 of pregnancy to induce diabetes mellitus. Offspring were evaluated on days $-$1, 1, 2, 5 and 10 of life. Parameters measured were body weight, plasma glucose and insulin, in vitro glucose-stimulated insulin release, and protein expression of GLUT1, GLUT2, and glucokinase by immunocytochemistry in the isolated islet and Western blot on the whole pancreas. The IDM had significantly lower mean body weights at all ages studied (p $&lt;$ 0.01, n $\\ge$ 34); significantly higher mean plasma glucose concentration at day $-$1 (p $&lt;$ 0.0001, n $\\ge$ 181) and significantly lower mean plasma glucose at all neonatal ages (p $&lt;$ 0.01, n $\\ge$ 36). Mean plasma insulin was significantly lower at all ages except for day 10 of life (p $&lt;$ 0.05, n $\\ge$ 26). The IDM group mean for the in vitro glucose-stimulated insulin release data was significantly greater than controls (p $&lt;$ 0.0001, n $\\ge$ 4). The insulin release in the IDM was significantly higher on specific days: day $-$1 at glucose concentration of 11.1 and 22.2 mmol/L (p $&lt;$ 0.05, n $\\ge$ 4); day 1 at glucose concentration of 5.5 mmol/L (p $&lt;$ 0.05, n = 6 experiments); and day 2 at glucose concentration of 11.1 mmol/L 22.2 mmol/L (p $&lt;$ 0.05, n $\\ge$ 6). By immunocytochemistry, the IDM had greater GLUT1 protein expression on days 1, 2, and 5 (n = 5 replicates); greater GLUT2 expression on days $-$1, 1, and 5 (n = 7 replicates); and greater glucokinase expression on days 1, 2, and 10 (n = 4 replicates). Western blot data revealed significantly lower GLUT2 protein expression in the IDM on days $-$1 and 2 (p $&lt;$ 0.05, n = 4). These data confirm the elevated insulin release in IDM and suggest that glucose transporter and glucokinase proteins involved in glucose sensing are altered in the IDM.","abstract_has_math":true,"creators":["Sullivan, Debra Kay"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Nutritional Sciences","degree_department":null,"school":null,"contributors":["Reynolds, Robert D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2015,"date_issued":"2015-09-25T22:31:11Z","date_published":"2015-09-25T22:31:11Z","updated_at":"2026-07-22T22:26:24Z","subjects":["Biology, Animal Physiology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["(MiAaPQ)AAI9812782"],"render_values":[{"text":"(MiAaPQ)AAI9812782","href":null,"code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/2142/84977","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Reynolds, Robert D."]},{"key":"dc:creator","label":"Author","values":["Sullivan, Debra Kay"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2015-09-25T22:31:11Z","10000-01-01","1997"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Nutritional Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biology, Animal Physiology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/84977","(MiAaPQ)AAI9812782"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Neonatal hypoglycemia is common in infants of diabetic mothers (IDM). The hypoglycemia is believed to result from persistent insulin hypersecretion due to the elevated glucose concentration in utero. The mechanism for the hypersecretion of insulin is not known. The glucose sensing mechanism in the fetal and neonatal IDM and normal control rats was investigated. Pregnant rats were given an i.p. injection of streptozotocin (65 mg/kg) on day 13 of pregnancy to induce diabetes mellitus. Offspring were evaluated on days $-$1, 1, 2, 5 and 10 of life. Parameters measured were body weight, plasma glucose and insulin, in vitro glucose-stimulated insulin release, and protein expression of GLUT1, GLUT2, and glucokinase by immunocytochemistry in the isolated islet and Western blot on the whole pancreas. The IDM had significantly lower mean body weights at all ages studied (p $<$ 0.01, n $\\ge$ 34); significantly higher mean plasma glucose concentration at day $-$1 (p $<$ 0.0001, n $\\ge$ 181) and significantly lower mean plasma glucose at all neonatal ages (p $<$ 0.01, n $\\ge$ 36). Mean plasma insulin was significantly lower at all ages except for day 10 of life (p $<$ 0.05, n $\\ge$ 26). The IDM group mean for the in vitro glucose-stimulated insulin release data was significantly greater than controls (p $<$ 0.0001, n $\\ge$ 4). The insulin release in the IDM was significantly higher on specific days: day $-$1 at glucose concentration of 11.1 and 22.2 mmol/L (p $<$ 0.05, n $\\ge$ 4); day 1 at glucose concentration of 5.5 mmol/L (p $<$ 0.05, n = 6 experiments); and day 2 at glucose concentration of 11.1 mmol/L 22.2 mmol/L (p $<$ 0.05, n $\\ge$ 6). By immunocytochemistry, the IDM had greater GLUT1 protein expression on days 1, 2, and 5 (n = 5 replicates); greater GLUT2 expression on days $-$1, 1, and 5 (n = 7 replicates); and greater glucokinase expression on days 1, 2, and 10 (n = 4 replicates). Western blot data revealed significantly lower GLUT2 protein expression in the IDM on days $-$1 and 2 (p $<$ 0.05, n = 4). These data confirm the elevated insulin release in IDM and suggest that glucose transporter and glucokinase proteins involved in glucose sensing are altered in the IDM.","Made available in DSpace on 2015-09-25T22:31:11Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 9812782.pdf: 7832432 bytes, checksum: cd848c46f393c269281fade1d38d283f (MD5) Previous issue date: 1997","Embargo set by: Seth Robbins for item 86258 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","U of I Only","191 p.","Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 1997."]},{"key":"dc:title","label":"Title","values":["Mechanism of Insulin Release From Islets of Langerhans in a Rat Model of Normal Infants and Infants of Diabetic Mothers"]}]}],"canonical_facts":{"dc:contributor":["Reynolds, Robert D."],"dc:creator":["Sullivan, Debra Kay"],"dc:date":["2015-09-25T22:31:11Z","10000-01-01","1997"],"dc:description":["Neonatal hypoglycemia is common in infants of diabetic mothers (IDM). The hypoglycemia is believed to result from persistent insulin hypersecretion due to the elevated glucose concentration in utero. The mechanism for the hypersecretion of insulin is not known. The glucose sensing mechanism in the fetal and neonatal IDM and normal control rats was investigated. Pregnant rats were given an i.p. injection of streptozotocin (65 mg/kg) on day 13 of pregnancy to induce diabetes mellitus. Offspring were evaluated on days $-$1, 1, 2, 5 and 10 of life. Parameters measured were body weight, plasma glucose and insulin, in vitro glucose-stimulated insulin release, and protein expression of GLUT1, GLUT2, and glucokinase by immunocytochemistry in the isolated islet and Western blot on the whole pancreas. The IDM had significantly lower mean body weights at all ages studied (p $<$ 0.01, n $\\ge$ 34); significantly higher mean plasma glucose concentration at day $-$1 (p $<$ 0.0001, n $\\ge$ 181) and significantly lower mean plasma glucose at all neonatal ages (p $<$ 0.01, n $\\ge$ 36). Mean plasma insulin was significantly lower at all ages except for day 10 of life (p $<$ 0.05, n $\\ge$ 26). The IDM group mean for the in vitro glucose-stimulated insulin release data was significantly greater than controls (p $<$ 0.0001, n $\\ge$ 4). The insulin release in the IDM was significantly higher on specific days: day $-$1 at glucose concentration of 11.1 and 22.2 mmol/L (p $<$ 0.05, n $\\ge$ 4); day 1 at glucose concentration of 5.5 mmol/L (p $<$ 0.05, n = 6 experiments); and day 2 at glucose concentration of 11.1 mmol/L 22.2 mmol/L (p $<$ 0.05, n $\\ge$ 6). By immunocytochemistry, the IDM had greater GLUT1 protein expression on days 1, 2, and 5 (n = 5 replicates); greater GLUT2 expression on days $-$1, 1, and 5 (n = 7 replicates); and greater glucokinase expression on days 1, 2, and 10 (n = 4 replicates). Western blot data revealed significantly lower GLUT2 protein expression in the IDM on days $-$1 and 2 (p $<$ 0.05, n = 4). These data confirm the elevated insulin release in IDM and suggest that glucose transporter and glucokinase proteins involved in glucose sensing are altered in the IDM.","Made available in DSpace on 2015-09-25T22:31:11Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 9812782.pdf: 7832432 bytes, checksum: cd848c46f393c269281fade1d38d283f (MD5) Previous issue date: 1997","Embargo set by: Seth Robbins for item 86258 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","U of I Only","191 p.","Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 1997."],"dc:identifier":["http://hdl.handle.net/2142/84977","(MiAaPQ)AAI9812782"],"dc:language":["eng"],"dc:subject":["Biology, Animal Physiology"],"dc:title":["Mechanism of Insulin Release From Islets of Langerhans in a Rat Model of Normal Infants and Infants of Diabetic Mothers"],"dc:type":["text"],"thesis:degree_discipline":["Nutritional Sciences"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:26:24Z"}